Synapse

← Paul M. Haller

Papers by Paul M. Haller

Page 1 · newest first

  1. Prevalence and diagnostic impact of standard modifiable risk factors in suspected myocardial infarctionEuropean Heart Journal · 2026
  2. High-sensitivity C-reactive protein in patients with suspected myocardial infarction classified to the observe zoneEuropean Heart Journal · 2026
  3. A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskJournal of the American College of Cardiology · 2025
  4. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2024
  5. Cardiac Troponin Assays to Distinguish Between Acute and Chronic Myocardial InjuryJournal of the American College of Cardiology · 2023
  6. Early versus delayed evolocumab treatment and complex coronary artery revascularizationEuropean Journal of Preventive Cardiology · 2026
  7. Prevalence and prognostic impact of myocardial injury following hypertensive crisisEuropean Heart Journal · 2023
  8. Diagnostic validation and prognostic implications of serial 0/1/3h stratification in patients with suspected myocardial infarction using high-sensitivity troponin TEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  9. Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trialsAmerican Journal of Epidemiology · 2025
  10. Galectin‐3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE‐TIMI 58ESC Heart Failure · 2025
  11. Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureCirculation · 2025
  12. Bedside echocardiography in patients with suspected acute myocardial infarction without ST elevationClinical Research in Cardiology · 2025
  13. Identification of patients with suspected NSTE-ACS in the observe zone: evaluating GRACE 1.0 score and a biomarker panel for risk stratification and management optimizationClinical Research in Cardiology · 2025
  14. A Common Algorithm for Cardiac Troponin to Rule Out and Rule in Acute Myocardial InfarctionCanadian Journal of Cardiology · 2025
  15. Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndromeClinical Research in Cardiology · 2024
  16. Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024
  17. Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarctionClinical Research in Cardiology · 2023
  18. Long-term outcome of patients presenting with myocardial injury or myocardial infarctionClinical Research in Cardiology · 2023
  19. Diagnostic and prognostic value of the sex-specific 99th percentile of four high-sensitivity cardiac troponin assays in patients with suspected myocardial infarctionEuropean Heart Journal Acute Cardiovascular Care · 2023
  20. The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndromeAtherosclerosis Plus · 2023
  21. Rising and Falling High‐Sensitivity Cardiac Troponin in Diagnostic Algorithms for Patients With Suspected Myocardial InfarctionJournal of the American Heart Association · 2023
  22. Personalized diagnosis in suspected myocardial infarctionClinical Research in Cardiology · 2023
  23. Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusEuropean Journal of Preventive Cardiology · 2023
  24. Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation StudyCells · 2023
  25. Validation of a 0/1 h Algorithm for Rapid Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I AssayClinical Chemistry · 2023
  26. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypesJournal of Molecular and Cellular Cardiology Plus · 2022
  27. Association of Plasma Methylglyoxal Increase after Myocardial Infarction and the Left Ventricular Ejection FractionSHILAP Revista de lepidopterología · 2022
  28. Relationship between plasma Neuregulin-1 and cardiac function in patients with ST-elevation myocardial infarctionReviews in Cardiovascular Medicine · 2022
  29. The association of anaemia and high-sensitivity cardiac troponin and its effect on diagnosing myocardial infarctionEuropean Heart Journal Acute Cardiovascular Care · 2021
  30. Sex-Based Differences in Autologous Cell Therapy Trials in Patients With Acute Myocardial Infarction: Subanalysis of the ACCRUE DatabaseFrontiers in Cardiovascular Medicine · 2021
  31. Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysisClinical Research in Cardiology · 2021
  32. Diagnostic Validation of a High-Sensitivity Cardiac Troponin I AssayClinical Chemistry · 2021
  33. Effect of marathon and ultra‐marathon on inflammation and iron homeostasisScandinavian Journal of Medicine and Science in Sports · 2020
  34. Role of Cardiac Biomarkers in Epidemiology and Risk OutcomesClinical Chemistry · 2020
  35. Immature cell fractions after cessation of chronic P2Y₁₂-inhibition in patients with coronary artery diseasesPlatelets · 2020
  36. Predictive Value of Serial ECGs in Patients with Suspected Myocardial InfarctionJournal of Clinical Medicine · 2020
  37. Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled TrialBiomedicines · 2020
  38. Clinical application of the 4th Universal Definition of Myocardial InfarctionEuropean Heart Journal · 2020
  39. Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With DiabetesDiabetes Care · 2019
  40. Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial InfarctionSHILAP Revista de lepidopterología · 2019
  41. MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery DiseaseThrombosis and Haemostasis · 2019
  42. The association of P2Y12 inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery diseasePlatelets · 2019
  43. Predictors of transportation delay in patients with suspected ST-elevation-myocardial infarction in the VIENNA-STEMI networkClinical Research in Cardiology · 2019
  44. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2019
  45. Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-StudyThrombosis and Haemostasis · 2019
  46. Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial InfarctionCirculation Research · 2018
  47. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trialsEuropean Heart Journal Acute Cardiovascular Care · 2018
  48. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 yearNephrology Dialysis Transplantation · 1996